Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Hemorrhage 12Neoplasms 7Leiomyoma 6Breast Neoplasms 6Thrombocytopenia 3Postoperative Hemorrhage 3Meningioma 3Hematologic Neoplasms 3Urinary Bladder Neoplasms 2Seroma 2Seizures 2Prostatic Neoplasms 2Myofibroma 2Menorrhagia 2Brain Neoplasms 2Bone Neoplasms 2Blood Loss, Surgical 2Wrist Fractures 1Urologic Diseases 1Urinary Tract Infections 1Urinary Retention 1Thromboembolism 1Stomach Neoplasms 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Skin Neoplasms 1Sepsis 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1

Interventions

Surgical Procedures, Operative 4Cabergoline 4Temozolomide 3Propofol 3Hydrocortisone 3Dexmedetomidine 3lanreotide 2Sevoflurane 2Saline Solution 2Rosiglitazone 2Radiotherapy 2Radiosurgery 2Proton Therapy 2Human Growth Hormone 2Desflurane 2Aminolevulinic Acid 2pasireotide 1parecoxib 1lutetium Lu 177 dotatate 1loxoprofen 1Yoga 1Visual Field Tests 1Visual Acuity 1Trimethoprim 1Transcranial Magnetic Stimulation 1Tranexamic Acid 1Tramadol 1Surveys and Questionnaires 1Supine Position 1Sulfamethoxazole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pituitary Neoplasms × Tranexamic Acid × Clear all
NCT04863339 2022-04-05

Tranexamic Acid for Blood Loss Minimization in Endoscopic Pituitary Surgery

University of North Carolina, Chapel Hill

Phase 2 Withdrawn
Endocrine

Hemorrhage, Pituitary Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡